A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins
about
Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivoCholesterol loading and ultrastable protein interactions determine the level of tumor marker required for optimal isolation of cancer cellsCurrent Landscape of Antiviral Drug DiscoveryStable long-term cultures of self-renewing B cells and their applicationsDynamic Viral Glycoprotein Machines: Approaches for Probing Transient States That Drive Membrane FusionHost Immunological Factors Enhancing Mortality of Young Adults during the 1918 Influenza PandemicDeveloping Universal Influenza Vaccines: Hitting the Nail, Not Just on the HeadThe role of Fc-FcγR interactions in IgG-mediated microbial neutralizationAntibody-Based Strategies to Prevent and Treat InfluenzaB Cells and Functional Antibody Responses to Combat InfluenzaStructural characterization of viral epitopes recognized by broadly cross-reactive antibodiesAdvances in structure-based vaccine designTelomeres and immune competencyPotential strategies and biosafety protocols used for dual-use research on highly pathogenic influenza virusesStructural insights on the role of antibodies in HIV-1 vaccine and therapyPeptide Vaccine: Progress and ChallengesInfluenza treatment and prophylaxis with neuraminidase inhibitors: a reviewRecent progress in structure-based anti-influenza drug designUniversal immunity to influenza must outwit immune evasionH5N1 vaccines in humansInfluenza virus hemagglutinin stalk-based antibodies and vaccinesBroadly neutralizing antibodies against influenza virus and prospects for universal therapiesHIV-1 envelope glycoprotein structureMechanisms of hemagglutinin targeted influenza virus neutralizationProtective efficacy of passive immunization with monoclonal antibodies in animal models of H5N1 highly pathogenic avian influenza virus infectionVaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A VirusesHighly Conserved Protective Epitopes on Influenza B VirusesCross-neutralization of influenza A viruses mediated by a single antibody loopInsights into Avian Influenza Virus Pathogenicity: the Hemagglutinin Precursor HA0 of Subtype H16 Has an Alpha-Helix Structure in Its Cleavage Site with Inefficient HA1/HA2 CleavageHeterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidityStructural vaccinology: structure-based design of influenza A virus hemagglutinin subtype-specific subunit vaccinesStructure of a Classical Broadly Neutralizing Stem Antibody in Complex with a Pandemic H2 Influenza Virus HemagglutininBroadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding GlycansStructure and Receptor Binding Specificity of Hemagglutinin H13 from Avian Influenza A Virus H13N6Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencingA Unique and Conserved Neutralization Epitope in H5N1 Influenza Viruses Identified by an Antibody against the A/Goose/Guangdong/1/96 HemagglutininAutoreactivity and Exceptional CDR Plasticity (but Not Unusual Polyspecificity) Hinder Elicitation of the Anti-HIV Antibody 4E10A common solution to group 2 influenza virus neutralizationInsight into Highly Conserved H1 Subtype-Specific Epitopes in Influenza Virus HemagglutininGenome-wide analyses reveal a highly conserved Dengue virus envelope peptide which is critical for virus viability and antigenic in humans
P2860
Q24568302-52AF1796-B7A4-408F-8B12-99B20408AB5CQ24594878-18DB27C7-E3AE-4C3B-A657-3771C6DF911EQ26766639-5613F7C9-F432-44BC-AA5B-CB118C00AC77Q26766723-383D1D40-001D-4BFE-9372-CC58AE26A0A2Q26772129-B0E0C163-4858-4E78-985B-43207066EF96Q26782795-CA9B58B6-4FD1-4DAC-9CE9-56F1782AD4F5Q26783897-8FCBB092-EAF1-4E10-A817-4FCC81F2F30EQ26797466-A5F528C1-5B8C-45EC-ACC8-BD28321117DDQ26798520-5FAE8C8B-A8BD-414E-BAB0-F736EFB989C6Q26801639-25FDBD97-C869-4A5F-9EB3-0CC0A13FC0A5Q26823492-7C4F8E25-0DCE-4A57-B89C-84A950CC7C63Q26824545-B1307ED3-7C63-438A-9577-CFA9DF20D96AQ26825318-B7A5D00A-88E0-4A4A-8301-E860F83FD6F4Q26825532-B6AED117-8CB2-4CD8-AE85-FC4EDFC65B30Q26829461-6A667B2E-9804-4C34-95DD-1BFA68F34501Q26851329-0FFAA4F4-9C73-4C01-93E7-60B3B04BDC2CQ26860032-33BE2E23-C6F0-4749-B083-DF37CCAFE947Q26863710-A4D11FF6-842D-46EF-9577-BFCFA358193AQ26991896-80415C2A-4242-41D6-ADF4-D7ED3B9153DEQ27000896-41779D5B-5D30-4F3B-A4D0-F14286050199Q27001190-13FF7951-F7E7-49D7-9F95-3BD809447EC7Q27010503-79C56763-55A2-4C5D-9943-7325F2A00782Q27011248-C9513E39-6162-4558-AF85-B83927A53F75Q27302234-1EAD6CD9-CB0E-4E7C-941A-BA18125E3945Q27324824-888FBAAC-B190-4425-9F75-7C4CC28A5778Q27644544-BDA78802-EE73-4843-8417-72347B9DB531Q27671404-C6106B28-72C8-4672-A54B-A48190AEF7A7Q27673206-99851C27-AB83-47AA-8851-6E064069D69DQ27673446-F727AB49-066B-4DF1-AB59-62A9FE42D614Q27673861-0F677BA1-BD9B-4945-93A3-74EC1A4D3163Q27676658-9F850F6B-5483-4E4C-A2C8-1C3866AD4467Q27677191-7A4F52C6-4F0F-4E70-959C-4D94F36BDCB0Q27678062-562B2FFE-3A7C-46F0-89AE-E5640D766D55Q27678588-62AACA40-49DE-415A-B8E9-A745440AB6E4Q27679309-EBE2F48C-7D42-4A72-AD83-09065D838B38Q27679987-4F782D09-06AC-497D-8C06-ABFB6A22D495Q27680125-0167E76C-6186-4B55-93F4-F2718856A1B2Q27680873-17CF35BC-5B51-4287-BA07-E97AF107ED72Q27681955-F3216128-1738-4DEA-8E3C-C0309430B566Q27682470-FE1CDE57-C7D3-40D3-9F02-F5C733A1836E
P2860
A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A neutralizing antibody select ...... p 2 influenza A hemagglutinins
@ast
A neutralizing antibody select ...... p 2 influenza A hemagglutinins
@en
A neutralizing antibody select ...... p 2 influenza A hemagglutinins
@nl
type
label
A neutralizing antibody select ...... p 2 influenza A hemagglutinins
@ast
A neutralizing antibody select ...... p 2 influenza A hemagglutinins
@en
A neutralizing antibody select ...... p 2 influenza A hemagglutinins
@nl
prefLabel
A neutralizing antibody select ...... p 2 influenza A hemagglutinins
@ast
A neutralizing antibody select ...... p 2 influenza A hemagglutinins
@en
A neutralizing antibody select ...... p 2 influenza A hemagglutinins
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
A neutralizing antibody select ...... p 2 influenza A hemagglutinins
@en
P2093
Andrea Minola
Annalisa Macagno
Blanca M Fernandez-Rodriguez
Chiara Silacci
David Jarrossay
Davide Corti
Debora Pinna
Fabrizia Vanzetta
Giosiana Codoni
Gloria Agatic
P2860
P3181
P356
10.1126/SCIENCE.1205669
P407
P577
2011-08-12T00:00:00Z